Lambert-Eaton myasthenic syndrome
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:autoimmune_disease
gptkb:muscular_dystrophy |
| gptkbp:abbreviation |
gptkb:LEMS
|
| gptkbp:affects |
neuromuscular junction
|
| gptkbp:associatedWith |
gptkb:Small_Cell_Lung_Cancer
|
| gptkbp:autoantibodyTarget |
P/Q-type voltage-gated calcium channels
|
| gptkbp:causedBy |
autoantibodies against voltage-gated calcium channels
|
| gptkbp:diagnosedBy |
electromyography
antibody testing |
| gptkbp:differentialDiagnosis |
gptkb:myasthenia_gravis
|
| gptkbp:firstDescribed |
1956
|
| gptkbp:ICD-10_code |
gptkb:G70.3
|
| gptkbp:namedAfter |
gptkb:Lee_Eaton
gptkb:Edward_Lambert |
| gptkbp:onset |
adulthood
|
| gptkbp:prevalence |
rare
|
| gptkbp:symptom |
muscle weakness
autonomic dysfunction dry mouth difficulty walking reduced tendon reflexes |
| gptkbp:treatment |
gptkb:3,4-diaminopyridine
gptkb:pyridostigmine immunosuppressants |
| gptkbp:bfsParent |
gptkb:paraneoplastic_syndromes
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lambert-Eaton myasthenic syndrome
|